Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2020-05 Issue:5 Volume:8 Page:407-417
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Leere Julius Simoni,Karmisholt Jesper,Robaczyk Maciej,Lykkeboe Simon,Handberg Aase,Steinkohl Emilie,Brøndum Frøkjær Jens,Vestergaard Peter

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Hyperparathyroidism;Bilezikian;Lancet,2018

2. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth International Workshop;Bilezikian;J Clin Endocrinol Metab,2014

3. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the management of asymptomatic primary hyperparathyroidism;Marcocci;J Clin Endocrinol Metab,2014

4. Contemporary medical management of primary hyperparathyroidism: a systematic review;Leere;Front Endocrinol,2017

5. Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism;Faggiano;Endocrine,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary hyperparathyroidism: from guidelines to outpatient clinic;Reviews in Endocrine and Metabolic Disorders;2024-08-20

2. Linea guida sulla gestione terapeutica dell’iperparatiroidismo primario sporadico nell’adulto;L'Endocrinologo;2024-03-13

3. Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and low bone Mass;Cardiorenal Medicine;2024-02-07

4. Surgical strategy in lithium‐associated hyperparathyroidism: A population‐based study;World Journal of Surgery;2024-01-12

5. Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3